A detailed history of Pale Fire Capital Se transactions in Celcuity Inc. stock. As of the latest transaction made, Pale Fire Capital Se holds 17,458 shares of CELC stock, worth $230,271. This represents 0.04% of its overall portfolio holdings.

Number of Shares
17,458
Previous 11,653 49.82%
Holding current value
$230,271
Previous $191 Million 36.37%
% of portfolio
0.04%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$13.98 - $19.15 $81,153 - $111,165
5,805 Added 49.82%
17,458 $260 Million
Q2 2024

Aug 13, 2024

BUY
$14.1 - $20.78 $19,514 - $28,759
1,384 Added 13.48%
11,653 $191 Million
Q1 2024

May 14, 2024

SELL
$13.74 - $21.6 $56,883 - $89,424
-4,140 Reduced 28.73%
10,269 $222 Million
Q4 2023

Feb 13, 2024

BUY
$8.7 - $15.02 $34,800 - $60,080
4,000 Added 38.43%
14,409 $210 Million
Q3 2023

Nov 13, 2023

BUY
$8.96 - $10.75 $93,264 - $111,896
10,409 New
10,409 $95.1 Million

Others Institutions Holding CELC

About Celcuity Inc.


  • Ticker CELC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,941,300
  • Market Cap $197M
  • Description
  • Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...
More about CELC
Track This Portfolio

Track Pale Fire Capital Se Portfolio

Follow Pale Fire Capital Se and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pale Fire Capital Se, based on Form 13F filings with the SEC.

News

Stay updated on Pale Fire Capital Se with notifications on news.